Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesSaluda Medical Inc

Saluda Medical Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.215 AUD 0.01 ( 2.38%)
Last update at 2026-11-12T05:19:00Z
VOLUME
245588
Market Cap
58.59M

Momentum Score

…

Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally. The company offers a closed-loop, dose-control platform which senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback. It provides Evoke, an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. The company was founded in 2011 and is based in Bloomington, Minnesota.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.21
Low
0.23
High
52 Week Price Range
0.23
Low
1.90
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Saluda Medical is an Australian medical‑device company focused on neuromodulation for chronic pain, developing a closed‑loop spinal cord stimulation system that measures neural responses to adjust therapy. Long-term growth drivers include clinical adoption of closed‑loop SCS, expansion into key markets and improved reimbursement, which may benefit revenue and position the company within the advanced pain‑therapy segment.

Principal risks are regulatory and reimbursement hurdles, competitive pressure from established SCS manufacturers, limited commercial scale and ongoing financing and execution risk.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.21
Dividend Yield
-
Revenue TTM
90.17M
Revenue Per Share
0.56
Gross Profit TTM
44.08M
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
-
Diluted EPS TTM
-0.88

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown
Breakdown
Breakdown 2025-06-30
Type yearly
Date 2025-06-30
Net income -149.30M
Capital expenditures 0.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
SLD
Saluda Medical Inc		 0.01
2.38%		 0.21 - - 0.65 -
COH
Cochlear Ltd		 2.26
1.50%		 152.98 68.64 27.40 4.30 5.34
IMR
Imricor Medical Systems Inc		 0.06
4.72%		 1.33 - - 36401.21 17.45
AVR
Anteris Technologies Global Corp		 0.50
5.88%		 9.00 - - 356.02 2.19
AVH
Avita Medical Inc		 -0.11
2.13%		 5.06 - 9.97 9.59 7.17

Profile*

Saluda Medical Inc

Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally. The company offers a closed-loop, dose-control platform which senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback. It provides Evoke, an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. The company was founded in 2011 and is based in Bloomington, Minnesota.

9401 James Avenue S, Bloomington, MN, United States, 55431

(857) 272-9585

https://www.saludamedical.com

Name Title Year Born
Mr. Barry J. Regan CEO, President & Director 1972
Mr. James Erickson Chief Financial Officer NA
Mr. Aidan O'Sullivan Chief Operations Officer NA
Dean Karantonis Chief Technology Officer NA
Ms. Kristin S. Caplice Chief Legal Officer & Secretary NA
Mr. David First Chief People Officer 1964
Mr. Michael Mathias Chief Commercial Officer NA
Mr. Michael Mathias President, CEO & Director NA
Dr. Dean Karantonis Chief Technology Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…